Stay updated on Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial page.

Latest updates to the Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3 on the site. The update represents an internal platform release with potential bug fixes and minor improvements, not changes to the study information.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded Hepatocellular carcinoma as a study topic and a new Resources link to the Genetic and Rare Diseases Information Center, and updated the site revision to v3.5.0 (replacing v3.4.3).SummaryDifference0.2%

- Check59 days agoChange DetectedSite revision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check73 days agoChange DetectedThe study status was updated to Terminated due to poor accrual, with termination dates added and the previous Completed status and completion dates removed.SummaryDifference0.3%

- Check87 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1. No substantive changes to the study details page were detected.SummaryDifference0.0%

Stay in the know with updates to Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial page.